Share

August 2013; 3 (4) Clinical and Ethical Challenges

Postmarketing adverse drug reactions

A duty to report?

Eran Klein, Dennis Bourdette
First published July 19, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e3182a1b9f0
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
923

Share

Article Information

vol. 3 no. 4 288-294
DOI: 
https://doi.org/10.1212/CPJ.0b013e3182a1b9f0
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published July 19, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Eran Klein, MD, PhD and
    2. Dennis Bourdette, MD
  1. Eran Klein, MD, PhD and
    2. Scientific Advisory Boards:

    1. 1. NIMH DSMB member

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1. AAN speaker honorarium

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. 1. Story of Bioethics, Georgetown University Press, 2003.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. Veterans Affairs, Geriatric Neurology fellowship, fellow, 2010-2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Dennis Bourdette, MD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. I have received honoraria for speaking from Biogen Idec and Teva Neurosciences.

    Editorial Boards:

    1. Journal of Medicinal Medicine, Associate Editor, 2009- present ; Current Neurology and Neuroscience Reports, Section Editor, 2008-2011; Autoimmune Diseases, Associate Editor, 2009-present; Neurology, Member Editorial Board, 2013- present. I receive no compensation for any of these activities.

    Patents:

    1. I have a use patent pending for the treatment of multiple sclerosis with cyclic peptide derivatives of cyclosporin.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. I have served as a consultant to Elan Corporation in the past 12 months.

    Speakers' Bureaus:

    1. I am a member of the Biogen Idec speaker's bureau.

    Other activities:

    1. I have received support for patient and physician education programs from Teva Neuroscience, Biogen Idec, EMD Serono and Novartis.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. NIH/NINDS, 1R01NS057433, PI,4/1/08-3/31/13 2. Department of Veterans Affairs/BLR&D, Merit Review, PI, 10/1/09-9/30/13

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National MS Society, CA 1055-A-3, PI, 4/1/08-3/31/13

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (EK, DB), Oregon Health & Science University; Neurology Service (EK, DB), Department of Veterans Affairs Medical Center; and MS Center of Excellence–West (DB), Department of Veterans Affairs Medical Center, Portland, OR.
  1. Correspondence to:
    kleine{at}ohsu.edu
View Full Text

Article usage

Article usage: July 2013 to June 2022

AbstractFullPdfSource
Jul 20133307Highwire
Aug 20134192020Highwire
Sep 201332819Highwire
Oct 201317222Highwire
Nov 20139303Highwire
Dec 20137411Highwire
Jan 20147622Highwire
Feb 20144400Highwire
Mar 20144202Highwire
Apr 20145810Highwire
May 20147241Highwire
Jun 20147221Highwire
Jul 20141700Highwire
Aug 20141800Highwire
Sep 20142300Highwire
Oct 20143411Highwire
Nov 20141301Highwire
Dec 20145001Highwire
Jan 20153610Highwire
Jan 20150102pmc
Feb 20153300Highwire
Feb 20150122pmc
Mar 20154101Highwire
Mar 2015056pmc
Apr 20152100Highwire
Apr 20150112pmc
May 20151302Highwire
May 20150170pmc
Jun 20151500Highwire
Jun 20150143pmc
Jul 20153200Highwire
Jul 20150131pmc
Aug 20152600Highwire
Aug 20150192pmc
Sep 20151800Highwire
Sep 20150214pmc
Oct 20151100Highwire
Oct 20150181pmc
Nov 20151702Highwire
Nov 20150242pmc
Dec 20153700Highwire
Dec 20150282pmc
Jan 20163402Highwire
Jan 20160217pmc
Feb 20162700Highwire
Feb 20160464pmc
Mar 20161800Highwire
Mar 20160180pmc
Apr 20161800Highwire
Apr 20160336pmc
May 20162500Highwire
May 20160865pmc
Jun 20163311Highwire
Jun 20160311pmc
Jul 20161200Highwire
Jul 20160357pmc
Aug 20162200Highwire
Aug 20160393pmc
Sep 20164402Highwire
Sep 20160524pmc
Oct 20163800Highwire
Oct 20160372pmc
Nov 20164000Highwire
Nov 20160657pmc
Dec 20164300Highwire
Dec 201601307pmc
Jan 20173900Highwire
Jan 20170622pmc
Feb 20172800Highwire
Feb 20170634pmc
Mar 20173100Highwire
Mar 20170986pmc
Apr 20172000Highwire
Apr 201735258pmc
May 20171600Highwire
May 201734149pmc
Jun 20171300Highwire
Jun 201746180pmc
Jul 2017600Highwire
Jul 201724155pmc
Aug 20171200Highwire
Aug 201725459pmc
Sep 2017500Highwire
Sep 201776273pmc
Oct 20172400Highwire
Oct 2017289100pmc
Nov 20172302Highwire
Nov 2017697115pmc
Dec 20171500Highwire
Jan 20182200Highwire
Feb 20183350Highwire
Mar 20184220Highwire
Apr 20184210Highwire
Apr 201846173pmc
May 20183500Highwire
Jun 20184000Highwire
Jun 201833853pmc
Jul 20183600Highwire
Aug 20183100Highwire
Aug 201844143pmc
Sep 20182000Highwire
Oct 20182600Highwire
Nov 20182100Highwire
Dec 20185300Highwire
Jan 20195100Highwire
Feb 20195000Highwire
Mar 20192410Highwire
Apr 20193221Highwire
May 20195040Highwire
Jun 20192710Highwire
Jul 20192500Highwire
Aug 20193201Highwire
Sep 20191210Highwire
Oct 2019910Highwire
Nov 20191411Highwire
Dec 2019910Highwire
Jan 20201110Highwire
Feb 20201310Highwire
Mar 20201010Highwire
Apr 2020900Highwire
May 20201200Highwire
Jun 2020200Highwire
Jul 20201610Highwire
Aug 20201500Highwire
Sep 20201400Highwire
Oct 20203000Highwire
Nov 20202503Highwire
Dec 20202220Highwire
Jan 20211220Highwire
Feb 20211420Highwire
Mar 20212120Highwire
Apr 20211200Highwire
May 2021210Highwire
Jun 20211520Highwire
Jul 20211340Highwire
Aug 20213550Highwire
Sep 2021740Highwire
Oct 20212741Highwire
Nov 2021920Highwire
Dec 2021720Highwire
Jan 20221700Highwire
Feb 20221333Highwire
Mar 20221920Highwire
Apr 20221500Highwire
May 20221300Highwire
Jun 2022600Highwire

The Nerve!: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me